End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
23.81 CNY | +0.13% | -1.49% | -4.87% |
15/05 | Fosun Pharma Unit Fosun Health to Receive Capital Injection from Foshan Chanxi City Investment | MT |
15/05 | China Approves Clinical Trials For Breast Cancer Drugs | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.87% | 793.87Cr | |
+34.35% | 69TCr | |
+29.39% | 58TCr | |
-3.49% | 37TCr | |
+20.15% | 33TCr | |
+6.19% | 29TCr | |
+14.11% | 24TCr | |
-3.03% | 21TCr | |
+10.02% | 21TCr | |
+9.21% | 17TCr |
- Stock Market
- Equities
- 600196 Stock
- News Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
- China Approves Fosun Unit's Phase 2 Clinical Trial for Cancer Combination Therapy